Board Members: Lloyd Minor
Lloyd Minor, MD
Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine
Appointed by State Controller
Lloyd B. Minor, MD, became dean of the Stanford University School of Medicine on December 1, 2012. The oldest medical school in the West, Stanford consistently ranks among the top U.S. medical schools with faculty members who secure the highest amount of research funding per investigator in the country. As dean, Minor is leading the Campaign for Stanford Medicine, which seeks to advance scientific innovation, clinical excellence, and interactive education at the school and at Stanford Hospital and Clinics and the Lucile Packard Children’s Hospital. Minor is also a professor of Otolaryngology–Head and Neck Surgery and a professor of Bioengineering and of Neurobiology, by courtesy.
Before coming to Stanford, Minor was provost and senior vice president of academic affairs of The Johns Hopkins University. During his time as provost, Minor launched many university-wide initiatives such as the Gateway Sciences Initiative to support pedagogical innovation and the Doctor of Philosophy Board to promote excellence in Ph.D. education. He worked with others around the university and health system to coordinate the Individualized Health Initiative, which aimed to use genetic information to transform health care.
Prior to his appointment as provost in 2009, Minor served as the Andelot Professor and director (chair) of the Department of Otolaryngology–Head and Neck Surgery in the Johns Hopkins University School of Medicine and otolaryngologist-in-chief of The Johns Hopkins Hospital. During his six-year tenure, he expanded annual research funding by more than half and increased clinical activity by more than 30 percent, while strengthening teaching efforts and student training.
With more than 140 published articles and chapters, Minor is an expert in balance and inner ear disorders. Through neurophysiological investigations of eye movements and neuronal pathways, his work has identified adaptive mechanisms responsible for compensation to vestibular injury in a model system for studies of motor learning (the vestibulo-ocular reflex). The synergies between this basic research and clinical studies have led to improved methods for the diagnosis and treatment of balance disorders. In recognition of his work in refining a treatment for Ménière’s disease, Minor received the Prosper Ménière Society’s gold medal in 2010.
In the medical community, Minor is perhaps best known for his discovery of superior canal dehiscence syndrome, a debilitating disorder characterized by sound- or pressure-induced dizziness. In 1998 Minor and colleagues published a description of the clinical manifestations of the syndrome and related its cause to an opening (dehiscence) in the bone covering the superior canal. He subsequently developed a surgical procedure that corrects the problem and alleviates symptoms.
Minor received his bachelor’s and medical degrees from Brown University, where he is a member of the Brown Medical School Committee. He trained at Duke University Medical Center and the University of Chicago Medical Center and completed a research fellowship at the University of Chicago and a clinical fellowship at The Otology Group and The EAR Foundation in Nashville, Tennessee.
In 2012, Minor was elected to the Institute of Medicine of the National Academy of Sciences.
Linda M. Boxer, M.D., Ph.D.,
Vice Dean Stanford University School of Medicine
Dr. Linda Boxer obtained her M.D. and Ph.D. degrees at Stanford University. She was an intern and resident in internal medicine at Stanford and then did a hematology/oncology fellowship at Stanford. She joined the faculty at Stanford in the Division of Hematology, Department of Medicine, and also had a position at the VA Palo Alto Health Care System. Dr. Boxer’s laboratory investigates the mechanisms of deregulated expression of oncogenes by translation into the immunoglobulin locus in B cells lymphomas. She has a clinical practice in hematology with an interest in hematologic malignancies. Since March 2004 she has been the Chief of the Division of Hematology, the director of the Clinical Investigator Pathway (the ABIM research pathway) in the Department of Medicine, and she was the hematology fellowship director for eight years. She has trained and mentored many physicians and physician scientists during this time. Dr. Boxer was the Interim Chair of the Department of Medicine for two years, and she was the Senior Vice Chair of the Department of Medicine for one year. She was appointed Vice Dean of the School of Medicine in September 2013.